Assort Health, the most advanced specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital.

This brings Assort Health's total capital raised to $26 million. These investors join Assort Health's existing backers, Four Acres, Tau Ventures, and a number of notable angel investors, including senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. The new capital will accelerate the company's mission to improve access to care by eliminating the lengthy hold times and scheduling inefficiencies that plague healthcare organizations.